<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Marcogliese PC</submitter><funding>NICHD NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>NHGRI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>ZonMw</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>110517</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8983390</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>38(11)</volume><pubmed_abstract>Individuals with autism spectrum disorder (ASD) exhibit an increased burden of de novo mutations (DNMs) in a broadening range of genes. While these studies have implicated hundreds of genes in ASD pathogenesis, which DNMs cause functional consequences in vivo remains unclear. We functionally test the effects of ASD missense DNMs using Drosophila through "humanization" rescue and overexpression-based strategies. We examine 79 ASD variants in 74 genes identified in the Simons Simplex Collection and find 38% of them to cause functional alterations. Moreover, we identify GLRA2 as the cause of a spectrum of neurodevelopmental phenotypes beyond ASD in 13 previously undiagnosed subjects. Functional characterization of variants in ASD candidate genes points to conserved neurobiological mechanisms </pubmed_abstract><journal>Cell reports</journal><pubmed_title>Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases.</pubmed_title><pmcid>PMC8983390</pmcid><funding_grant_id>R25 GM069234</funding_grant_id><funding_grant_id>R25 GM056929</funding_grant_id><funding_grant_id>P50 HD103555</funding_grant_id><funding_grant_id>F30 MH118804</funding_grant_id><funding_grant_id>R24 OD022005</funding_grant_id><funding_grant_id>U54 HD083092</funding_grant_id><funding_grant_id>R01 HG009141</funding_grant_id><funding_grant_id>T32 GM007526</funding_grant_id><funding_grant_id>91617021</funding_grant_id><funding_grant_id>F32 NS110174</funding_grant_id><funding_grant_id>UM1 HG008900</funding_grant_id><pubmed_authors>Harnish JM</pubmed_authors><pubmed_authors>Keren B</pubmed_authors><pubmed_authors>Marom R</pubmed_authors><pubmed_authors>German RJ</pubmed_authors><pubmed_authors>Bhadane P</pubmed_authors><pubmed_authors>Perrin L</pubmed_authors><pubmed_authors>Delanne J</pubmed_authors><pubmed_authors>Mau-Them FT</pubmed_authors><pubmed_authors>Chao HT</pubmed_authors><pubmed_authors>Strehlow V</pubmed_authors><pubmed_authors>Chao YH</pubmed_authors><pubmed_authors>Keller R</pubmed_authors><pubmed_authors>England E</pubmed_authors><pubmed_authors>Brusco A</pubmed_authors><pubmed_authors>Graves HK</pubmed_authors><pubmed_authors>Yamamoto S</pubmed_authors><pubmed_authors>Trajkova S</pubmed_authors><pubmed_authors>Fehr S</pubmed_authors><pubmed_authors>van Dooren MF</pubmed_authors><pubmed_authors>Schwaibold EMC</pubmed_authors><pubmed_authors>Wangler MF</pubmed_authors><pubmed_authors>Bhavana VH</pubmed_authors><pubmed_authors>Pavinato L</pubmed_authors><pubmed_authors>Rosenfeld JA</pubmed_authors><pubmed_authors>Liu N</pubmed_authors><pubmed_authors>Lesca G</pubmed_authors><pubmed_authors>Chatron N</pubmed_authors><pubmed_authors>Leiz S</pubmed_authors><pubmed_authors>Barakat TS</pubmed_authors><pubmed_authors>Jangam S</pubmed_authors><pubmed_authors>Wilke M</pubmed_authors><pubmed_authors>Brownstein CA</pubmed_authors><pubmed_authors>Hull B</pubmed_authors><pubmed_authors>Andrews J</pubmed_authors><pubmed_authors>Haelterman NA</pubmed_authors><pubmed_authors>Platzer K</pubmed_authors><pubmed_authors>Lee PT</pubmed_authors><pubmed_authors>Sukarova-Angelovska E</pubmed_authors><pubmed_authors>Huang MC</pubmed_authors><pubmed_authors>Rosenhahn E</pubmed_authors><pubmed_authors>Guerrini R</pubmed_authors><pubmed_authors>Bei D</pubmed_authors><pubmed_authors>Gerard A</pubmed_authors><pubmed_authors>Chung HL</pubmed_authors><pubmed_authors>van Slegtenhorst M</pubmed_authors><pubmed_authors>Marcogliese PC</pubmed_authors><pubmed_authors>Deal SL</pubmed_authors><pubmed_authors>Courtin T</pubmed_authors><pubmed_authors>Madden JA</pubmed_authors><pubmed_authors>Longley CM</pubmed_authors><pubmed_authors>Vetro A</pubmed_authors><pubmed_authors>Sabatier I</pubmed_authors><pubmed_authors>Agrawal PB</pubmed_authors><pubmed_authors>Pan H</pubmed_authors><pubmed_authors>Kanca O</pubmed_authors><pubmed_authors>Manivannan SN</pubmed_authors><pubmed_authors>Rossetti LZ</pubmed_authors><pubmed_authors>Murali CN</pubmed_authors><pubmed_authors>Roser T</pubmed_authors><pubmed_authors>Luo X</pubmed_authors><pubmed_authors>Brugger M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases.</name><description>Individuals with autism spectrum disorder (ASD) exhibit an increased burden of de novo mutations (DNMs) in a broadening range of genes. While these studies have implicated hundreds of genes in ASD pathogenesis, which DNMs cause functional consequences in vivo remains unclear. We functionally test the effects of ASD missense DNMs using Drosophila through "humanization" rescue and overexpression-based strategies. We examine 79 ASD variants in 74 genes identified in the Simons Simplex Collection and find 38% of them to cause functional alterations. Moreover, we identify GLRA2 as the cause of a spectrum of neurodevelopmental phenotypes beyond ASD in 13 previously undiagnosed subjects. Functional characterization of variants in ASD candidate genes points to conserved neurobiological mechanisms </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-31T18:02:25.744Z</modification><creation>2025-04-05T22:20:00.871Z</creation></dates><accession>S-EPMC8983390</accession><cross_references><pubmed>35294868</pubmed><doi>10.1016/j.celrep.2022.110517</doi></cross_references></HashMap>